全球风疹与先天性风疹综合征消除进展(2012—2022年)
本报告更新全球风疹和先天性风疹综合征(CRS)消除进展。2012—2022年,194个WHO国家中含风疹疫苗(RCV)免疫规划的国家从132个(68%)增至175个(90%),全球婴儿接种风疹疫苗比例从40%升至68%,报告风疹病例从93,816例降至17,407例(下降81%),98个(51%)国家实现消除验证。
要点
- 2012—2022年含风疹疫苗免疫规划国家从132个(68%)增至175个(90%)。
- 全球婴儿风疹疫苗接种率从40%升至68%,报告风疹病例下降81%。
研究设计与样本
- 本报告为全球风疹和先天性风疹综合征消除进展的更新报告,描述2012—2022年期间194个WHO国家的进展。
主要发现
- 2012—2022年,194个WHO国家中含风疹疫苗(RCV)免疫规划的国家从132个(68%)增至175个(90%)。
- 全球婴儿接种风疹疫苗的比例从40%升至68%。
- 报告风疹病例从2012年93,816例降至2022年17,407例,下降81%。
- 截至2022年,98个(51%)国家实现风疹消除验证,较2019年84个(43%)增加。
关键数值与推荐
- 2012—2022年含RCV免疫规划国家从132个(68%)增至175个(90%)。
- 全球婴儿风疹疫苗接种率从40%升至68%。
- 报告风疹病例从93,816例(2012年)降至17,407例(2022年),下降81%。
- 2022年98个(51%)国家实现风疹消除验证,2019年为84个(43%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rubella virus is a leading cause of vaccine-preventable birth defects. Infection during pregnancy can result in miscarriage, fetal death, stillbirth, or a constellation of birth defects, including cataracts, deafness, heart defects, and developmental delay, known as congenital rubella syndrome (CRS). A single dose of rubella-containing vaccine can provide lifelong protection against rubella. The Global Vaccine Action Plan 2011-2020 included a target to achieve elimination of rubella in at least five of the six World Health Organization (WHO) regions by 2020, and rubella elimination is a critical goal of the Immunization Agenda 2030. This report updates a previous report and describes progress toward rubella and CRS elimination during 2012-2022. During 2012-2022, among 194 WHO countries, the number that included rubella-containing vaccine (RCV) in their immunization schedules increased from 132 (68%) to 175 (90%) and the percentage of the world's infants vaccinated against rubella increased from 40% to 68%. Reported rubella cases declined 81%, from 93,816 in 2012 to 17,407 in 2022. Verification of rubella elimination was achieved in 98 (51%) of 194 countries by 2022, an increase from 84 (43%) countries in 2019. Despite significant progress in the introduction of RCV into routine immunization programs worldwide, approximately 25 million infants annually still do not have access to RCV. Nevertheless, even in complex settings, the increasing number of countries that have achieved and sustained rubella elimination demonstrates progress toward global rubella elimination.
引用
- Ou AC, Zimmerman LA, Alexander JP, et al. Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38421933. doi:10.15585/mmwr.mm7308a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。